Revision history of "Arronax: fitting-out works for premises" (Q3699316)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 13:2613:26, 9 October 2024DG Regio talk contribs 63,186 bytes +1 Changed label, description and/or aliases in pt
  • curprev 13:2613:26, 9 October 2024DG Regio talk contribs 63,185 bytes +17 Set a claim value: summary (P836): O ArronaxPlus é um equipamento de excelência selecionado no programa de financiamento de equipamentos Investissements d’Avenir (Equipex) (2012-2019). Liderada pela GIP Arronax, envolve cinco parceiros: SUBATECH, o Centro Regional de Investigação do Cancro de Nantes/Angers (CRCNA), o Departamento de Medicina Nuclear do CHU Nantes, o Institut de Cancérologie de l’Ouest, o Laboratório de Investigação em Química Orgânica do Ceisam e a Escola Veterinária...

7 March 2024

12 January 2024

9 June 2023

8 June 2023

11 August 2022

  • curprev 23:3223:32, 11 August 2022DG Regio talk contribs 59,904 bytes +41,120 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

14 January 2022

13 January 2022

6 December 2021

1 December 2021

  • curprev 12:1212:12, 1 December 2021DG Regio talk contribs 12,284 bytes +2,087 Created claim: summary (P836): ArronaxPlus ist eine hervorragende Ausrüstung, die im Programm zur Finanzierung von Exzellenzausrüstungen (Equipex) für Investitionen in Zukunft (2012-2019) aufgeführt ist. Unter der Leitung der IPG Arronax sind fünf Partner beteiligt: SUBATECH, das Regionale Zentrum für Krebsforschung Nantes/Angers (CRCNA), die Abteilung für Nuklearmedizin der CHU in Nantes, das Institut für Karzinologie des Westens, das Forschungslabor für organische Chemie C...

27 November 2021

  • curprev 13:2313:23, 27 November 2021DG Regio talk contribs 10,197 bytes −2,140 Removed claim: summary (P836): ArronaxPlus est un équipement d‚excellence retenu dans le programme de financement des Equipements d‘Excellence (Equipex) des Investissements d’Avenir (2012-2019). Piloté par le GIP Arronax, il associe cinq partenaires: Subatech, le Centre Régional de Recherche en Cancérologie Nantes/Angers (CRCNA), le département de Médecine Nucléaire du CHU de Nantes, l‚Institut de Cancérologie de l‘Ouest, le laboratoire de recherche en chimie organique Cei...
  • curprev 01:3101:31, 27 November 2021DG Regio talk contribs 12,337 bytes +2,140 Created claim: summary (P836): ArronaxPlus est un équipement d‚excellence retenu dans le programme de financement des Equipements d‘Excellence (Equipex) des Investissements d’Avenir (2012-2019). Piloté par le GIP Arronax, il associe cinq partenaires: Subatech, le Centre Régional de Recherche en Cancérologie Nantes/Angers (CRCNA), le département de Médecine Nucléaire du CHU de Nantes, l‚Institut de Cancérologie de l‘Ouest, le laboratoire de recherche en chimie organique Ceisa...

26 November 2021

24 November 2021

22 November 2021

  • curprev 11:3611:36, 22 November 2021DG Regio talk contribs 9,662 bytes +98 Changed label, description and/or aliases in en: translated_label
  • curprev 11:3611:36, 22 November 2021DG Regio talk contribs 9,564 bytes +1,956 Created claim: summary (P836): ArronaxPlus is an equipment of excellence selected in the Investissements d’Avenir (Equipex) equipment financing program (2012-2019). Led by GIP Arronax, it involves five partners: SUBATECH, the Nantes/Angers Regional Centre for Cancer Research (CRCNA), the Department of Nuclear Medicine of the CHU Nantes, the Institut de Cancérologie de l’Ouest, the Ceisam Organic Chemistry Research Laboratory and the Oniris Veterinary School. In particular,...

17 November 2021